Healthcare Sector Stocks
The Healthcare sector has a total of 1047 stocks, with a combined market cap of $9.69 trillion, total revenue of $4.73 trillion and a weighted average PE ratio of 45.48.
Market Cap
9.69T
Revenue
4.73T
Profits
212.93B
PE Ratio
45.48
Profit Margin
4.50%
Dividend Yield
0.39%
1046 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.23T | -2.32% | 2,883,474 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 656.47B | -2.15% | 7,939,122 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 505.56B | -2.33% | 4,853,927 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 339.66B | -3.90% | 9,704,412 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 313.53B | -10.21% | 17,394,118 | 450.06B |
| 6 | NVS | Novartis AG | 294.48B | -2.46% | 2,766,148 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 278.14B | -1.93% | 2,537,896 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 256.67B | 0.87% | 2,075,619 | 47.35B |
| 9 | AMGN | Amgen Inc. | 240.11B | -3.07% | 2,585,286 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 209.59B | -0.75% | 4,962,968 | 30.99B |
| 11 | ABT | Abbott Laboratories | 180.95B | -0.22% | 7,604,977 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 175.56B | -3.12% | 16,566,886 | 50.70B |
| 13 | DHR | Danaher Corporation | 160.81B | 1.24% | 2,942,981 | 25.61B |
| 14 | PFE | Pfizer Inc. | 159.94B | -1.44% | 37,655,701 | 63.62B |
| 15 | ISRG | Intuitive Surgical, Inc. | 145.92B | -2.23% | 2,214,547 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 136.01B | 0.42% | 1,292,404 | 12.95B |
| 17 | MCK | McKesson Corporation | 125.20B | -0.66% | 674,520 | 418.79B |
| 18 | MDT | Medtronic plc | 123.30B | -1.56% | 6,871,998 | 37.54B |
| 19 | BMY | Bristol-Myers Squibb Company | 121.75B | -2.92% | 11,109,108 | 50.03B |
| 20 | SYK | Stryker Corporation | 121.12B | 0.19% | 3,284,324 | 26.30B |
| 21 | SNY | Sanofi | 113.30B | -0.86% | 2,319,626 | 57.89B |
| 22 | CVS | CVS Health Corporation | 104.09B | -5.20% | 17,590,767 | 418.16B |
| 23 | HCA | HCA Healthcare, Inc. | 99.51B | -4.96% | 1,606,442 | 78.70B |
| 24 | GSK | GSK plc | 97.88B | -1.34% | 2,201,814 | 44.53B |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 94.88B | -1.28% | 705,145 | 16.90B |
| 26 | ELV | Elevance Health, Inc. | 86.60B | -7.63% | 1,908,109 | 201.83B |
| 27 | MRNA | Moderna, Inc. | 79.63B | -4.84% | 6,986,350 | 2.53B |
| 28 | CI | The Cigna Group | 75.20B | -2.96% | 2,493,898 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 68.89B | -1.71% | 3,422,065 | 29.86B |
| 30 | COR | Cencora, Inc. | 66.47B | -0.64% | 1,367,722 | 337.40B |
| 31 | CAH | Cardinal Health, Inc. | 64.33B | -0.33% | 1,479,780 | 257.75B |
| 32 | BSX | Boston Scientific Corporation | 63.26B | 1.42% | 13,248,139 | 21.07B |
| 33 | EW | Edwards Lifesciences Corporation | 60.51B | -0.19% | 3,923,271 | 6.67B |
| 34 | ARGX | argenx SE | 58.93B | -0.66% | 309,893 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 58.86B | 0.31% | 1,319,942 | 19.46B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 55.03B | 1.19% | 373,686 | 4.66B |
| 37 | MDLN | Medline Inc. | 51.51B | 3.93% | 40,692,766 | 30.68B |
| 38 | A | Agilent Technologies, Inc. | 49.99B | 2.97% | 2,489,277 | 7.37B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 49.28B | -0.92% | 8,873,226 | 17.23B |
| 40 | HUM | Humana Inc. | 46.33B | -12.98% | 4,156,242 | 154.19B |
| 41 | ONC | BeOne Medicines AG | 46.10B | -2.34% | 243,134 | 6.45B |
| 42 | WAT | Waters Corporation | 45.81B | 3.63% | 734,159 | 5.61B |
| 43 | VEEV | Veeva Systems Inc. | 44.88B | -3.89% | 2,747,550 | 3.46B |
| 44 | IQV | IQVIA Holdings Inc. | 42.49B | 0.09% | 1,398,966 | 17.31B |
| 45 | NTRA | Natera, Inc. | 41.98B | 0.71% | 1,960,019 | 2.91B |
| 46 | HLN | Haleon plc | 39.65B | 0.33% | 19,460,943 | 14.80B |
| 47 | RPRX | Royalty Pharma plc | 39.39B | -0.01% | 3,361,571 | 2.62B |
| 48 | GEHC | GE HealthCare Technologies Inc. | 37.83B | 2.22% | 3,650,989 | 21.64B |
| 49 | BIIB | Biogen Inc. | 37.16B | 0.25% | 1,144,883 | 10.30B |
| 50 | ALC | Alcon Inc. | 35.50B | 1.55% | 4,767,709 | 10.98B |
| 51 | ZTS | Zoetis Inc. | 34.77B | 2.50% | 4,664,357 | 9.49B |
| 52 | RVMD | Revolution Medicines, Inc. | 34.57B | -1.76% | 2,340,166 | 197.56M |
| 53 | MTD | Mettler-Toledo International Inc. | 34.55B | 1.42% | 157,753 | 4.20B |
| 54 | RMD | ResMed Inc. | 34.12B | 2.00% | 1,240,430 | 5.73B |
| 55 | CNC | Centene Corporation | 33.39B | -7.03% | 6,295,869 | 180.41B |
| 56 | GMAB | Genmab A/S | 32.46B | -1.91% | 2,957,021 | 4.30B |
| 57 | ILMN | Illumina, Inc. | 31.75B | 3.65% | 1,628,197 | 4.54B |
| 58 | DXCM | DexCom, Inc. | 30.78B | 0.59% | 4,249,573 | 5.10B |
| 59 | LH | Labcorp Holdings Inc. | 30.11B | 0.69% | 722,223 | 14.59B |
| 60 | PHG | Koninklijke Philips N.V. | 29.11B | -0.27% | 1,452,572 | 20.16B |
| 61 | DGX | Quest Diagnostics Incorporated | 28.57B | 1.30% | 1,301,915 | 11.84B |
| 62 | WST | West Pharmaceutical Services, Inc. | 28.14B | -2.44% | 595,819 | 3.40B |
| 63 | ROIV | Roivant Sciences Ltd. | 28.06B | 0.05% | 3,724,439 | 41.08M |
| 64 | INSM | Insmed Incorporated | 26.28B | -1.69% | 1,944,160 | 1.52B |
| 65 | STE | STERIS plc | 25.21B | 0.84% | 874,230 | 6.17B |
| 66 | UTHR | United Therapeutics Corporation | 24.59B | -1.16% | 433,869 | 3.19B |
| 67 | INCY | Incyte Corporation | 24.01B | -1.08% | 1,211,020 | 6.01B |
| 68 | VTRS | Viatris Inc. | 23.25B | -0.83% | 13,271,634 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 21.60B | -3.80% | 1,574,359 | 22.15B |
| 70 | BNTX | BioNTech SE | 20.64B | -1.89% | 1,242,097 | 2.75B |
| 71 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.01B | -4.54% | 2,518,054 | 5.01B |
| 72 | GH | Guardant Health, Inc. | 19.64B | 1.30% | 1,498,540 | 1.28B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 19.55B | 1.20% | 2,344,369 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.09B | -0.95% | 211,740 | 2.84B |
| 75 | ASND | Ascendis Pharma A/S | 17.73B | -0.32% | 568,039 | 1.37B |
| 76 | RVTY | Revvity, Inc. | 17.02B | 3.14% | 1,094,251 | 2.94B |
| 77 | EXEL | Exelixis, Inc. | 16.66B | -0.31% | 1,818,737 | 2.50B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 16.48B | -1.84% | 1,600,739 | 3.70B |
| 79 | CRL | Charles River Laboratories International, Inc. | 15.97B | 0.33% | 516,509 | 3.98B |
| 80 | JAZZ | Jazz Pharmaceuticals plc | 15.90B | 2.93% | 721,425 | 4.72B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 15.20B | 1.58% | 3,652,471 | 945.54M |
| 82 | SOLV | Solventum Corporation | 14.68B | 0.49% | 764,911 | 8.16B |
| 83 | ICLR | ICON Public Limited Company | 14.62B | 0.07% | 548,486 | 8.23B |
| 84 | BTSG | BrightSpring Health Services, Inc. | 14.24B | -2.13% | 1,809,854 | 15.25B |
| 85 | GKOS | Glaukos Corporation | 13.79B | -4.18% | 1,132,346 | 690.33M |
| 86 | BAX | Baxter International Inc. | 13.53B | 1.55% | 4,008,582 | 11.61B |
| 87 | ELAN | Elanco Animal Health Incorporated | 13.35B | 3.29% | 5,777,032 | 5.15B |
| 88 | EHC | Encompass Health Corporation | 13.24B | -2.14% | 841,555 | 6.34B |
| 89 | PEN | Penumbra, Inc. | 12.64B | 0.47% | 214,392 | 1.56B |
| 90 | SNN | Smith & Nephew plc | 12.62B | -0.62% | 1,215,158 | 6.30B |
| 91 | RDY | Dr. Reddy's Laboratories Limited | 12.45B | 1.28% | 1,788,497 | 3.44B |
| 92 | BMRN | BioMarin Pharmaceutical Inc. | 11.90B | 4.99% | 3,067,025 | 3.66B |
| 93 | TEM | Tempus AI, Inc. | 11.60B | 0.30% | 5,369,847 | 1.51B |
| 94 | ALGN | Align Technology, Inc. | 11.56B | 0.31% | 892,056 | 4.16B |
| 95 | COO | The Cooper Companies, Inc. | 11.55B | 0.05% | 2,198,717 | 4.24B |
| 96 | TECH | Bio-Techne Corporation | 11.43B | 0.17% | 2,628,447 | 1.23B |
| 97 | RGEN | Repligen Corporation | 11.04B | 6.47% | 1,298,717 | 805.61M |
| 98 | HALO | Halozyme Therapeutics, Inc. | 10.92B | -0.18% | 1,609,280 | 1.80B |
| 99 | FMS | Fresenius Medical Care AG | 10.88B | -3.41% | 1,918,894 | 22.12B |
| 100 | MOH | Molina Healthcare, Inc. | 10.76B | -6.62% | 1,332,022 | 42.08B |
| 101 | UHS | Universal Health Services, Inc. | 10.73B | -3.08% | 674,061 | 18.35B |
| 102 | ENSG | The Ensign Group, Inc. | 10.58B | -1.63% | 273,774 | 5.67B |
| 103 | AVTR | Avantor, Inc. | 10.41B | 1.25% | 5,940,236 | 6.64B |
| 104 | KYMR | Kymera Therapeutics, Inc. | 10.34B | -0.32% | 677,504 | 102.24M |
| 105 | QGEN | Qiagen N.V. | 10.23B | -0.38% | 4,255,131 | 2.12B |
| 106 | DVA | DaVita Inc. | 10.18B | -6.48% | 1,116,345 | 14.17B |
| 107 | BIO | Bio-Rad Laboratories, Inc. | 9.95B | 3.34% | 460,475 | 2.59B |
| 108 | PODD | Insulet Corporation | 9.71B | -3.69% | 2,087,923 | 3.19B |
| 109 | BRKR | Bruker Corporation | 9.66B | 3.10% | 1,726,074 | 3.51B |
| 110 | SYRE | Spyre Therapeutics, Inc. | 9.64B | 8.15% | 1,371,887 | - |
| 111 | HSIC | Henry Schein, Inc. | 9.47B | 3.32% | 2,083,114 | 13.73B |
| 112 | KRYS | Krystal Biotech, Inc. | 9.34B | 5.62% | 345,855 | 470.03M |
| 113 | GMED | Globus Medical, Inc. | 9.34B | 0.77% | 1,427,326 | 3.14B |
| 114 | HNGE | Hinge Health, Inc. | 9.31B | 0.10% | 1,277,760 | 800.82M |
| 115 | PCVX | Vaxcyte, Inc. | 9.26B | -1.48% | 1,128,790 | - |
| 116 | TGTX | TG Therapeutics, Inc. | 9.26B | 5.44% | 1,870,858 | 897.76M |
| 117 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.25B | -5.67% | 634,561 | 1.43B |
| 118 | MTRI | Mentari Therapeutics, Inc. | 9.19B | -12.66% | 215,226 | - |
| 119 | ATR | AptarGroup, Inc. | 8.98B | 0.95% | 336,933 | 3.99B |
| 120 | OSCR | Oscar Health, Inc. | 8.56B | -7.61% | 7,398,739 | 17.47B |
| 121 | PRAX | Praxis Precision Medicines, Inc. | 8.53B | 0.04% | 425,744 | 7.46M |
| 122 | SMMT | Summit Therapeutics Inc. | 8.40B | -1.59% | 12,095,254 | - |
| 123 | PTGX | Protagonist Therapeutics, Inc. | 8.30B | 2.00% | 432,808 | 551.69M |
| 124 | RYTM | Rhythm Pharmaceuticals, Inc. | 8.25B | 2.08% | 2,126,707 | 280.75M |
| 125 | HQY | HealthEquity, Inc. | 8.05B | -4.45% | 1,292,073 | 1.36B |
| 126 | TWST | Twist Bioscience Corporation | 7.93B | 3.88% | 2,226,182 | 459.43M |
| 127 | ALKS | Alkermes plc | 7.87B | 3.08% | 1,408,596 | 1.75B |
| 128 | AMRX | Amneal Pharmaceuticals, Inc. | 7.62B | 3.60% | 2,009,492 | 3.20B |
| 129 | TXG | 10x Genomics, Inc. | 7.51B | 1.37% | 2,095,758 | 618.58M |
| 130 | GRFS | Grifols, S.A. | 7.50B | -1.85% | 588,953 | 8.63B |
| 131 | BLCO | Bausch + Lomb Corporation | 7.49B | 0.58% | 511,363 | 5.42B |
| 132 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.47B | -0.06% | 327,563 | 945.96M |
| 133 | CORT | Corcept Therapeutics Incorporated | 7.42B | -3.25% | 744,849 | 963.65M |
| 134 | PACS | PACS Group, Inc. | 7.35B | -4.63% | 784,563 | 5.71B |
| 135 | ABVX | ABIVAX Société Anonyme | 7.33B | 2.11% | 1,194,760 | 5.33M |
| 136 | CYTK | Cytokinetics, Incorporated | 7.15B | -0.64% | 1,594,482 | 113.29M |
| 137 | CGON | CG Oncology, Inc. | 7.15B | 1.34% | 1,796,102 | 6.17M |
| 138 | IBRX | ImmunityBio, Inc. | 7.13B | 7.03% | 15,869,693 | 182.57M |
| 139 | CHE | Chemed Corporation | 7.09B | -0.01% | 169,034 | 2.66B |
| 140 | AXSM | Axsome Therapeutics, Inc. | 7.05B | -1.43% | 743,588 | 865.27M |
| 141 | IMVT | Immunovant, Inc. | 6.86B | -0.12% | 907,602 | - |
| 142 | LNTH | Lantheus Holdings, Inc. | 6.67B | 0.20% | 946,679 | 1.56B |
| 143 | TFX | Teleflex Incorporated | 6.58B | 3.95% | 1,160,573 | 2.26B |
| 144 | ORKA | Oruka Therapeutics, Inc. | 6.49B | -0.60% | 520,534 | - |
| 145 | KOD | Kodiak Sciences Inc. | 6.38B | 1.04% | 744,722 | - |
| 146 | BLTE | Belite Bio, Inc | 6.29B | -0.94% | 94,254 | - |
| 147 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.09B | 0.28% | 2,421,436 | 450.82M |
| 148 | MIRM | Mirum Pharmaceuticals, Inc. | 6.04B | 0.59% | 498,219 | 670.78M |
| 149 | SUPN | Supernus, Inc. | 6.02B | -0.28% | 2,715,309 | 1.37B |
| 150 | LGND | Ligand Pharmaceuticals Incorporated | 5.98B | 1.67% | 381,389 | 253.83M |
| 151 | SRRK | Scholar Rock Holding Corporation | 5.86B | 6.48% | 2,774,430 | 570.00K |
| 152 | RDNT | RadNet, Inc. | 5.66B | -4.14% | 812,093 | 2.38B |
| 153 | HAE | Haemonetics Corporation | 5.59B | 1.60% | 486,366 | 1.38B |
| 154 | CAI | Caris Life Sciences, Inc. | 5.59B | -2.21% | 3,916,387 | 1.05B |
| 155 | DOCS | Doximity, Inc. | 5.47B | -1.41% | 2,272,045 | 661.58M |
| 156 | CON | Concentra Group Holdings Parent, Inc. | 5.31B | -0.94% | 742,800 | 2.34B |
| 157 | WAY | Waystar Holding Corp. | 5.30B | -0.47% | 1,256,610 | 1.26B |
| 158 | MANE | Veradermics, Incorporated | 5.27B | -0.62% | 265,391 | - |
| 159 | LFST | LifeStance Health Group, Inc. | 5.24B | -2.82% | 6,598,711 | 1.68B |
| 160 | LIVN | LivaNova PLC | 5.21B | 2.85% | 1,321,127 | 1.51B |
| 161 | MMSI | Merit Medical Systems, Inc. | 5.15B | 1.70% | 493,821 | 1.61B |
| 162 | LQDA | Liquidia Corporation | 5.08B | -0.58% | 1,316,419 | 621.87M |
| 163 | PTCT | PTC Therapeutics, Inc. | 5.03B | -0.22% | 642,751 | 1.16B |
| 164 | COGT | Cogent Biosciences, Inc. | 4.84B | -0.14% | 2,705,363 | - |
| 165 | ERAS | Erasca, Inc. | 4.83B | -0.94% | 8,941,554 | - |
| 166 | TVTX | Travere Therapeutics, Inc. | 4.82B | -1.68% | 844,306 | 651.03M |
| 167 | MMED | MiniMed Group, Inc. | 4.78B | -4.44% | 4,702,278 | 3.22B |
| 168 | OPCH | Option Care Health, Inc. | 4.75B | 0.25% | 3,158,385 | 5.75B |
| 169 | DNTH | Dianthus Therapeutics, Inc. | 4.73B | -3.45% | 861,558 | 2.72M |
| 170 | SHC | Sotera Health Company | 4.65B | 1.43% | 1,966,289 | 1.23B |
| 171 | ADPT | Adaptive Biotechnologies Corporation | 4.61B | -0.11% | 2,209,955 | 298.01M |
| 172 | GRAL | GRAIL, Inc. | 4.59B | -3.57% | 627,461 | 166.60M |
| 173 | IONS | Ionis Pharmaceuticals, Inc. | 4.56B | 1.59% | 3,226,884 | 960.09M |
| 174 | EWTX | Edgewise Therapeutics, Inc. | 4.53B | -1.59% | 866,813 | - |
| 175 | ICUI | ICU Medical, Inc. | 4.46B | 0.89% | 214,942 | 2.18B |
| 176 | BLLN | BillionToOne, Inc. | 4.37B | -6.11% | 1,442,540 | 436.87M |
| 177 | STVN | Stevanato Group S.p.A. | 4.20B | 0.72% | 608,613 | 1.42B |
| 178 | HTFL | HeartFlow, Inc. | 4.03B | -2.51% | 1,333,130 | 238.66M |
| 179 | HIMS | Hims & Hers Health, Inc. | 4.00B | -2.85% | 9,591,447 | 2.87B |
| 180 | DFTX | Definium Therapeutics, Inc. | 3.99B | -0.88% | 1,915,329 | - |
| 181 | CDNA | CareDx, Inc. | 3.91B | -0.16% | 537,120 | 497.40M |
| 182 | CRSP | CRISPR Therapeutics AG | 3.90B | 0.10% | 3,978,927 | 25.17M |
| 183 | NVST | Envista Holdings Corporation | 3.81B | 0.21% | 1,916,200 | 2.88B |
| 184 | TARS | Tarsus Pharmaceuticals, Inc. | 3.74B | -2.88% | 456,221 | 682.20M |
| 185 | XENE | Xenon Pharmaceuticals Inc. | 3.71B | -2.66% | 1,364,350 | 7.50M |
| 186 | TNGX | Tango Therapeutics, Inc. | 3.71B | -1.00% | 2,746,145 | 53.81M |
| 187 | SLS | SELLAS Life Sciences Group, Inc. | 3.66B | -6.27% | 35,754,759 | - |
| 188 | OGN | Organon & Co. | 3.66B | 0.14% | 3,898,502 | 6.10B |
| 189 | RLAY | Relay Therapeutics, Inc. | 3.65B | 0.24% | 2,463,223 | 10.35M |
| 190 | ABCL | AbCellera Biologics Inc. | 3.60B | -0.09% | 2,591,183 | 67.85M |
| 191 | PBLS | Parabilis Medicines, Inc. | 3.57B | 0.78% | 602,343 | 2.26M |
| 192 | IRON | Disc Medicine, Inc. | 3.55B | 1.84% | 949,757 | - |
| 193 | WRBY | Warby Parker Inc. | 3.51B | 8.87% | 5,899,815 | 934.66M |
| 194 | SGRY | Surgery Partners, Inc. | 3.50B | 0.41% | 3,237,982 | 3.36B |
| 195 | ACHC | Acadia Healthcare Company, Inc. | 3.49B | -0.92% | 1,692,401 | 3.41B |
| 196 | ARQT | Arcutis Biotherapeutics, Inc. | 3.49B | 1.02% | 837,679 | 508.68M |
| 197 | IOVA | Iovance Biotherapeutics, Inc. | 3.46B | -0.66% | 7,008,731 | 378.98M |
| 198 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.42B | -3.27% | 1,510,531 | -665.00K |
| 199 | VRDN | Viridian Therapeutics, Inc. | 3.42B | 0.20% | 1,493,085 | 26.31M |
| 200 | AXGN | Axogen, Inc. | 3.40B | 2.85% | 2,114,849 | 266.93M |
| 201 | PLSE | Pulse Biosciences, Inc. | 3.37B | 2.21% | 332,035 | 1.49M |
| 202 | TMDX | TransMedics Group, Inc. | 3.35B | 2.68% | 1,075,478 | 727.65M |
| 203 | VKTX | Viking Therapeutics, Inc. | 3.34B | -2.64% | 2,888,048 | - |
| 204 | ELVN | Enliven Therapeutics, Inc. | 3.30B | -4.18% | 747,582 | - |
| 205 | BHC | Bausch Health Companies Inc. | 3.27B | 3.07% | 7,062,086 | 11.11B |
| 206 | IRTC | iRhythm Holdings, Inc. | 3.19B | 5.80% | 1,198,937 | 854.04M |
| 207 | NHC | National HealthCare Corporation | 3.16B | -2.03% | 96,095 | 1.58B |
| 208 | LEGN | Legend Biotech Corporation | 3.15B | 0.87% | 2,152,080 | 1.36B |
| 209 | PRVA | Privia Health Group, Inc. | 3.14B | -1.56% | 2,382,203 | 2.43B |
| 210 | XERS | Xeris Biopharma Holdings, Inc. | 3.10B | 1.13% | 2,762,516 | 368.26M |
| 211 | GRDN | Guardian Pharmacy Services, Inc. | 3.09B | -2.96% | 451,694 | 1.46B |
| 212 | ACAD | Acadia Pharmaceuticals Inc. | 3.08B | -2.67% | 1,895,605 | 1.20B |
| 213 | TLX | Telix Pharmaceuticals Limited | 3.01B | 1.13% | 418,746 | 890.79M |
| 214 | ADMA | ADMA Biologics, Inc. | 3.01B | -0.51% | 3,178,042 | 519.15M |
| 215 | VCEL | Vericel Corporation | 2.99B | 1.33% | 832,419 | 324.17M |
| 216 | DYN | Dyne Therapeutics, Inc. | 2.97B | -0.94% | 2,928,460 | - |
| 217 | DNLI | Denali Therapeutics Inc. | 2.95B | 2.22% | 2,368,841 | 21.38M |
| 218 | ATRC | AtriCure, Inc. | 2.82B | 0.78% | 621,469 | 589.80M |
| 219 | CELC | Celcuity Inc. | 2.73B | -4.15% | 1,017,407 | - |
| 220 | PGNY | Progyny, Inc. | 2.66B | -1.50% | 913,444 | 1.34B |
| 221 | MBX | MBX Biosciences, Inc. | 2.65B | 0.60% | 726,473 | - |
| 222 | XNCR | Xencor, Inc. | 2.58B | -0.32% | 867,068 | 200.49M |
| 223 | IDYA | IDEAYA Biosciences, Inc. | 2.56B | -3.32% | 1,452,452 | 36.54M |
| 224 | ZLAB | Zai Lab Limited | 2.49B | -6.03% | 1,042,532 | 441.73M |
| 225 | HCM | HUTCHMED (China) Limited | 2.48B | -2.85% | 35,798 | 549.12M |
| 226 | NEOG | Neogen Corporation | 2.42B | 1.65% | 1,785,964 | 884.00M |
| 227 | PBH | Prestige Consumer Healthcare Inc. | 2.40B | 4.98% | 618,464 | 1.17B |
| 228 | AVAH | Aveanna Healthcare Holdings Inc. | 2.37B | -6.91% | 2,127,099 | 2.68B |
| 229 | UFPT | UFP Technologies, Inc. | 2.37B | 2.74% | 89,516 | 649.52M |
| 230 | NAMS | NewAmsterdam Pharma Company N.V. | 2.37B | 1.81% | 1,795,455 | 25.94M |
| 231 | PRGO | Perrigo Company plc | 2.35B | 7.49% | 2,567,920 | 4.09B |
| 232 | MD | Pediatrix Medical Group, Inc. | 2.35B | -0.93% | 638,501 | 1.96B |
| 233 | RGC | Regencell Bioscience Holdings Limited | 2.33B | 3.08% | 78,307 | - |
| 234 | RCUS | Arcus Biosciences, Inc. | 2.27B | -3.84% | 1,973,101 | 100.00M |
| 235 | PHVS | Pharvaris N.V. | 2.23B | -2.26% | 390,157 | - |
| 236 | CLOV | Clover Health Investments, Corp. | 2.23B | -11.84% | 8,072,530 | 2.74B |
| 237 | ADUS | Addus HomeCare Corporation | 2.21B | -0.58% | 228,353 | 1.50B |
| 238 | LKFT | Lakefront Biotherapeutics NV | 2.20B | -0.93% | 148,433 | 1.13B |
| 239 | CLDX | Celldex Therapeutics, Inc. | 2.16B | -1.75% | 679,591 | 158.00K |
| 240 | PVLA | Palvella Therapeutics, Inc. | 2.14B | 1.54% | 118,875 | - |
| 241 | ALMR | Alamar Biosciences, Inc. | 2.12B | -0.42% | 525,156 | 114.05M |
| 242 | ESTA | Establishment Labs Holdings Inc. | 2.11B | 1.86% | 379,867 | 264.03M |
| 243 | BEAM | Beam Therapeutics Inc. | 2.09B | 1.74% | 4,866,853 | 146.64M |
| 244 | VCYT | Veracyte, Inc. | 2.06B | 5.53% | 2,447,412 | 581.78M |
| 245 | BKD | Brookdale Senior Living Inc. | 2.06B | -2.39% | 4,890,454 | 2.86B |
| 246 | SDGR | Schrödinger, Inc. | 2.04B | 6.00% | 1,178,698 | 269.20M |
| 247 | AZTA | Azenta, Inc. | 2.03B | 6.29% | 695,944 | 621.70M |
| 248 | ARDT | Ardent Health, Inc. | 2.03B | -18.87% | 7,270,111 | 6.45B |
| 249 | AUPH | Aurinia Pharmaceuticals Inc. | 2.03B | -1.75% | 761,774 | 321.74M |
| 250 | IMNM | Immunome, Inc. | 1.98B | -2.33% | 1,412,355 | 4.02M |
| 251 | NEO | NeoGenomics, Inc. | 1.98B | 0.26% | 1,090,777 | 787.75M |
| 252 | FTRE | Fortrea Holdings Inc. | 1.98B | 4.65% | 1,592,963 | 2.67B |
| 253 | BHVN | Biohaven Ltd. | 1.95B | -2.57% | 2,323,924 | - |
| 254 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | 0.30% | 565,813 | 989.36M |
| 255 | TRLV | Trulieve Cannabis Corp. | 1.93B | -0.50% | 954,609 | 1.08B |
| 256 | TRVI | Trevi Therapeutics, Inc. | 1.93B | 0.00% | 2,065,583 | - |
| 257 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.92B | 1.37% | 1,408,355 | 213.00M |
| 258 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.88B | -2.67% | 2,954,637 | 961.51M |
| 259 | REPL | Replimune Group, Inc. | 1.88B | 0.61% | 2,130,075 | - |
| 260 | SEPN | Septerna, Inc. | 1.88B | -1.42% | 298,914 | 96.27M |
| 261 | TRAX | First Tracks Biotherapeutics, Inc. | 1.87B | 2.13% | 751,349 | - |
| 262 | VERA | Vera Therapeutics, Inc. | 1.85B | -2.37% | 949,036 | 10.28M |
| 263 | COAG | Hemab Therapeutics Holdings, Inc. | 1.83B | 0.23% | 301,257 | - |
| 264 | LYCA | Lycia Therapeutics, Inc. | 1.81B | 1.39% | 383,466 | 4.44M |
| 265 | RARE | Ultragenyx Pharmaceutical Inc. | 1.80B | 6.17% | 5,164,233 | 730.00M |
| 266 | ZYME | Zymeworks Inc. | 1.80B | 0.77% | 1,085,747 | 265.97M |
| 267 | ZBIO | Zenas BioPharma, Inc. | 1.79B | -4.79% | 480,035 | 11.00M |
| 268 | ETON | Eton Pharmaceuticals, Inc. | 1.79B | -2.61% | 488,514 | 141.06M |
| 269 | AGIO | Agios Pharmaceuticals, Inc. | 1.78B | -0.70% | 600,069 | 140.84M |
| 270 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | 3.86% | 41,205,210 | 68.23M |
| 271 | STOK | Stoke Therapeutics, Inc. | 1.75B | 1.06% | 972,224 | 28.21M |
| 272 | LMAT | LeMaitre Vascular, Inc. | 1.73B | -0.68% | 222,726 | 269.36M |
| 273 | MAZE | Maze Therapeutics, Inc. | 1.71B | -5.08% | 711,473 | 20.00M |
| 274 | CERT | Certara, Inc. | 1.71B | 1.08% | 1,746,129 | 425.76M |
| 275 | HCSG | Healthcare Services Group, Inc. | 1.69B | 1.66% | 618,760 | 1.88B |
| 276 | XRAY | DENTSPLY SIRONA Inc. | 1.69B | -0.93% | 5,404,816 | 3.58B |
| 277 | KMTS | Kestra Medical Technologies, Ltd. | 1.69B | 0.07% | 437,969 | 106.73M |
| 278 | INSP | Inspire Medical Systems, Inc. | 1.68B | -2.19% | 505,923 | 880.94M |
| 279 | BFLY | Butterfly Network, Inc. | 1.63B | 5.74% | 4,778,582 | 123.26M |
| 280 | ALVO | Alvotech | 1.62B | 4.12% | 1,561,415 | 492.31M |
| 281 | PSNL | Personalis, Inc. | 1.62B | 1.22% | 1,466,521 | 80.77M |
| 282 | OMCL | Omnicell, Inc. | 1.59B | 1.94% | 341,291 | 1.24B |
| 283 | SNDA | Sonida Senior Living, Inc. | 1.57B | -0.46% | 501,279 | 593.56M |
| 284 | VIR | Vir Biotechnology, Inc. | 1.57B | -1.08% | 2,154,877 | 302.80M |
| 285 | ENOV | Enovis Corporation | 1.56B | -0.44% | 887,080 | 2.31B |
| 286 | SRPT | Sarepta Therapeutics, Inc. | 1.56B | -1.62% | 1,866,560 | 1.96B |
| 287 | WGS | GeneDx Holdings Corp. | 1.56B | 9.88% | 1,710,528 | 460.78M |
| 288 | NRIX | Nurix Therapeutics, Inc. | 1.54B | -0.98% | 2,790,318 | 701.94M |
| 289 | PGEN | Precigen, Inc. | 1.53B | -0.47% | 4,269,983 | 156.94M |
| 290 | KLRA | Kailera Therapeutics, Inc. | 1.53B | -3.36% | 418,798 | - |
| 291 | AGL | agilon health, inc. | 1.52B | -21.41% | 788,652 | 6.00B |
| 292 | ASTH | Astrana Health, Inc. | 1.52B | -7.31% | 521,855 | 3.91B |
| 293 | KRSA | Korsana Biosciences, Inc. | 1.52B | 2.37% | 247,335 | - |
| 294 | ANIP | ANI Pharmaceuticals, Inc. | 1.51B | 2.11% | 292,855 | 1.04B |
| 295 | BRVE | Braveheart Bio, Inc. | 1.51B | -1.33% | 706,902 | - |
| 296 | MESO | Mesoblast Limited | 1.49B | -2.27% | 132,572 | 120.25M |
| 297 | TDOC | Teladoc Health, Inc. | 1.47B | -5.06% | 3,966,982 | 2.47B |
| 298 | URGN | UroGen Pharma Ltd. | 1.46B | -0.27% | 1,144,304 | 250.25M |
| 299 | AMN | AMN Healthcare Services, Inc. | 1.45B | -1.31% | 551,180 | 3.52B |
| 300 | PRCT | PROCEPT BioRobotics Corporation | 1.45B | 5.89% | 2,048,990 | 352.31M |
| 301 | PAHC | Phibro Animal Health Corporation | 1.44B | 1.86% | 109,163 | 1.54B |
| 302 | CNMD | CONMED Corporation | 1.43B | -0.79% | 359,688 | 1.37B |
| 303 | USPH | U.S. Physical Therapy, Inc. | 1.42B | -1.96% | 330,680 | 829.86M |
| 304 | QURE | uniQure N.V. | 1.42B | -2.31% | 1,283,831 | 20.17M |
| 305 | DMRA | Damora Therapeutics, Inc. | 1.42B | 1.86% | 580,483 | - |
| 306 | IMCR | Immunocore Holdings plc | 1.42B | -1.08% | 296,509 | 429.30M |
| 307 | ABSI | Absci Corporation | 1.41B | 7.92% | 5,667,576 | 1.49M |
| 308 | ALHC | Alignment Healthcare, Inc. | 1.41B | -11.81% | 6,793,203 | 4.94B |
| 309 | ANAB | AnaptysBio, Inc. | 1.40B | 3.18% | 566,852 | 60.04M |
| 310 | RAPP | Rapport Therapeutics, Inc. | 1.39B | -1.52% | 731,316 | 20.00M |
| 311 | NTLA | Intellia Therapeutics, Inc. | 1.37B | -0.10% | 7,232,873 | 52.89M |
| 312 | ADRX | ADARx Pharmaceuticals, Inc. | 1.37B | -7.24% | 654,561 | 6.13M |
| 313 | TYRA | Tyra Biosciences, Inc. | 1.35B | 0.20% | 472,164 | - |
| 314 | LMRI | Lumexa Imaging Holdings, Inc. | 1.35B | -4.24% | 256,553 | 1.06B |
| 315 | NBTX | Nanobiotix S.A. | 1.34B | -2.00% | 44,323 | 13.15M |
| 316 | GENB | Generate Biomedicines, Inc. | 1.34B | 5.49% | 1,050,277 | 21.07M |
| 317 | NUVB | Nuvation Bio Inc. | 1.33B | -3.08% | 5,957,129 | 201.73M |
| 318 | WWB | Windward Bio Group AG | 1.31B | -12.11% | 517,961 | - |
| 319 | NVAX | Novavax, Inc. | 1.31B | 0.00% | 4,260,736 | 411.65M |
| 320 | MNKD | MannKind Corporation | 1.31B | 0.00% | 2,293,549 | 413.37M |
| 321 | INVA | Innoviva, Inc. | 1.31B | 0.55% | 1,310,687 | 438.32M |
| 322 | OCUL | Ocular Therapeutix, Inc. | 1.31B | -1.33% | 3,668,107 | 50.38M |
| 323 | TSHA | Taysha Gene Therapies, Inc. | 1.30B | -0.25% | 3,551,736 | 5.49M |
| 324 | LBRX | LB Pharmaceuticals Inc | 1.30B | -0.60% | 356,412 | - |
| 325 | STAA | STAAR Surgical Company | 1.27B | -0.82% | 451,281 | 328.27M |
| 326 | SVRA | Savara Inc. | 1.27B | 5.36% | 5,542,168 | - |
| 327 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.27B | 2.10% | 526,375 | 745.79M |
| 328 | PNTG | The Pennant Group, Inc. | 1.26B | -1.89% | 434,986 | 1.17B |
| 329 | OPK | OPKO Health, Inc. | 1.25B | 4.32% | 3,062,903 | 654.10M |
| 330 | NVCR | NovoCure Limited | 1.25B | -3.68% | 1,411,353 | 725.39M |
| 331 | GHRS | GH Research PLC | 1.25B | -0.11% | 461,979 | - |
| 332 | GPCR | Structure Therapeutics Inc. | 1.24B | -4.46% | 1,100,378 | - |
| 333 | SLN | Silence Therapeutics plc | 1.23B | 0.10% | 1,471,176 | 456.00K |
| 334 | AVLN | Avalyn Pharma Inc. | 1.23B | -0.82% | 404,759 | - |
| 335 | MLYS | Mineralys Therapeutics, Inc. | 1.22B | -4.83% | 1,392,765 | - |
| 336 | INNV | InnovAge Holding Corp. | 1.22B | -5.41% | 535,133 | 1.02B |
| 337 | HROW | Harrow, Inc. | 1.21B | 8.94% | 865,222 | 303.25M |
| 338 | TNDM | Tandem Diabetes Care, Inc. | 1.19B | -0.06% | 2,351,456 | 1.08B |
| 339 | NUTX | Nutex Health Inc. | 1.19B | -1.01% | 157,377 | 796.53M |
| 340 | NKTR | Nektar Therapeutics | 1.18B | -4.15% | 811,349 | 52.19M |
| 341 | CRON | Cronos Group Inc. | 1.17B | -0.63% | 1,130,343 | 206.20M |
| 342 | AHG | Akso Health Group | 1.16B | 9.57% | 1,676 | 13.83M |
| 343 | AAPG | Ascentage Pharma Group International | 1.16B | -0.97% | 1,803 | 94.61M |
| 344 | KARD | Kardigan, Inc. | 1.15B | -6.60% | 546,424 | - |
| 345 | CMPS | COMPASS Pathways plc | 1.15B | 1.75% | 2,354,851 | - |
| 346 | GDRX | GoodRx Holdings, Inc. | 1.15B | -3.17% | 659,271 | 785.23M |
| 347 | DRTS | Alpha Tau Medical Ltd. | 1.11B | -0.66% | 641,832 | - |
| 348 | VOR | Vor Biopharma Inc. | 1.10B | -1.93% | 794,108 | - |
| 349 | ATEC | Alphatec Holdings, Inc. | 1.10B | 1.73% | 2,796,643 | 839.72M |
| 350 | OMER | Omeros Corporation | 1.08B | 4.53% | 2,530,168 | 74.36M |
| 351 | IART | Integra LifeSciences Holdings Corporation | 1.08B | 2.29% | 575,208 | 1.66B |
| 352 | JBIO | Jade Biosciences, Inc. | 1.07B | 0.58% | 792,228 | - |
| 353 | SIBN | SI-BONE, Inc. | 1.06B | 1.64% | 1,119,999 | 220.65M |
| 354 | IRMD | IRADIMED CORPORATION | 1.05B | -1.37% | 78,813 | 89.34M |
| 355 | FRNM | Freenome, Inc. | 1.05B | -0.92% | 1,057,438 | 217.86M |
| 356 | ANRO | Alto Neuroscience, Inc. | 1.04B | 4.01% | 986,175 | - |
| 357 | CSTL | Castle Biosciences, Inc. | 1.03B | 1.21% | 380,849 | 377.13M |
| 358 | INBX | Inhibrx Biosciences, Inc. | 1.02B | -6.90% | 288,903 | 2.00M |
| 359 | CBLL | CeriBell, Inc. | 995.34M | -1.31% | 410,341 | 108.72M |
| 360 | SGP | SpyGlass Pharma, Inc. | 993.14M | -5.60% | 94,929 | - |
| 361 | AHCO | AdaptHealth Corp. | 984.56M | -2.12% | 1,537,217 | 3.44B |
| 362 | SPTX | Seaport Therapeutics, Inc. | 980.14M | 0.77% | 683,621 | - |
| 363 | GMRS | GMR Solutions Inc. | 968.17M | -4.29% | 1,022,804 | 5.97B |
| 364 | IMTX | Immatics N.V. | 928.83M | -3.02% | 1,571,188 | 49.33M |
| 365 | MLTX | MoonLake Immunotherapeutics | 918.30M | -4.09% | 1,346,238 | - |
| 366 | ODTX | Odyssey Therapeutics, Inc. | 909.92M | -2.01% | 369,093 | 99.00K |
| 367 | AORT | Artivion, Inc. | 904.56M | 1.48% | 913,980 | 481.88M |
| 368 | AKTS | Aktis Oncology, Inc. | 898.35M | -1.29% | 435,008 | 12.39M |
| 369 | BVS | Bioventus Inc. | 894.85M | 0.19% | 697,246 | 585.64M |
| 370 | LTGO | Latigo Biotherapeutics, Inc. | 882.44M | -3.27% | 209,071 | - |
| 371 | PHAR | Pharming Group N.V. | 866.88M | 3.51% | 5,958 | 386.75M |
| 372 | VSTM | Verastem, Inc. | 865.72M | -7.29% | 3,968,907 | 100.30M |
| 373 | CRVS | Corvus Pharmaceuticals, Inc. | 859.56M | 0.20% | 987,678 | - |
| 374 | HSTM | HealthStream, Inc. | 832.60M | -1.63% | 399,153 | 327.95M |
| 375 | CTY | City Therapeutics, Inc. | 827.95M | -4.91% | 252,983 | 14.34M |
| 376 | KIDS | OrthoPediatrics Corp. | 826.40M | 0.76% | 159,695 | 264.14M |
| 377 | OMDA | Omada Health, Inc. | 817.04M | -6.46% | 1,679,293 | 333.04M |
| 378 | MGTX | MeiraGTx Holdings plc | 813.12M | -1.65% | 584,715 | 401.91M |
| 379 | BBTX | Bambusa Therapeutics, Inc. | 809.98M | -2.75% | 253,223 | - |
| 380 | COLL | Collegium Pharmaceutical, Inc. | 805.79M | 1.49% | 494,458 | 815.19M |
| 381 | RIGL | Rigel Pharmaceuticals, Inc. | 800.84M | -0.91% | 304,828 | 288.21M |
| 382 | ORIC | ORIC Pharmaceuticals, Inc. | 795.08M | -4.37% | 1,385,239 | - |
| 383 | IRWD | Ironwood Pharmaceuticals, Inc. | 791.33M | -1.85% | 2,217,541 | 400.30M |
| 384 | ARDX | Ardelyx, Inc. | 784.28M | -1.89% | 4,746,261 | 468.22M |
| 385 | BBNX | Beta Bionics, Inc. | 779.08M | -2.65% | 1,376,417 | 127.27M |
| 386 | GLUE | Monte Rosa Therapeutics, Inc. | 775.03M | 0.00% | 1,264,758 | 70.33M |
| 387 | CTKB | Cytek Biosciences, Inc. | 774.24M | 3.86% | 1,048,764 | 207.65M |
| 388 | SNDX | Syndax Pharmaceuticals, Inc. | 770.64M | -6.96% | 3,465,199 | 289.68M |
| 389 | LXRX | Lexicon Pharmaceuticals, Inc. | 765.80M | -3.37% | 2,018,983 | 38.54M |
| 390 | VREX | Varex Imaging Corporation | 764.98M | 0.28% | 726,735 | 865.00M |
| 391 | PHR | Phreesia, Inc. | 760.99M | -2.39% | 859,095 | 507.79M |
| 392 | OBX | Obsidian Therapeutics, Inc. | 754.25M | 1.16% | 686,209 | - |
| 393 | IVA | Inventiva S.A. | 753.92M | 5.28% | 3,537,750 | 2.81M |
| 394 | AURA | Aura Biosciences, Inc. | 743.09M | -0.14% | 687,826 | - |
| 395 | OABI | OmniAb, Inc. | 740.97M | 0.59% | 1,215,050 | 40.21M |
| 396 | INMD | InMode Ltd. | 740.35M | -0.31% | 342,189 | 373.60M |
| 397 | APMD | Apnimed, Inc. | 726.46M | -1.97% | 297,565 | 108.80M |
| 398 | SGMT | Sagimet Biosciences Inc. | 721.53M | 2.64% | 932,576 | - |
| 399 | ATTO | Attovia Therapeutics, Inc. | 709.92M | 4.51% | 337,158 | 1.44M |
| 400 | SLDB | Solid Biosciences Inc. | 708.73M | 1.93% | 1,206,408 | - |
| 401 | FLGT | Fulgent Genetics, Inc. | 702.11M | 3.80% | 392,960 | 330.28M |
| 402 | IAM | Iambic Therapeutics, Inc. | 699.64M | 3.80% | 377,970 | 18.25M |
| 403 | NVCT | Nuvectis Pharma, Inc. | 697.75M | 5.68% | 189,615 | - |
| 404 | DCTH | Delcath Systems, Inc. | 685.32M | 1.70% | 591,077 | 109.96M |
| 405 | PRME | Prime Medicine, Inc. | 681.67M | -0.52% | 4,621,884 | 7.06M |
| 406 | KURA | Kura Oncology, Inc. | 674.39M | -2.00% | 2,466,840 | 79.31M |
| 407 | ANNX | Annexon, Inc. | 671.49M | 1.44% | 2,976,150 | - |
| 408 | QDEL | QuidelOrtho Corporation | 656.62M | -3.04% | 2,128,292 | 2.59B |
| 409 | QUIT | Achieve Life Sciences, Inc. | 651.40M | -3.27% | 969,433 | - |
| 410 | SOPH | SOPHiA GENETICS SA | 639.87M | 0.27% | 607,258 | 90.97M |
| 411 | GERN | Geron Corporation | 638.38M | -0.91% | 34,974,668 | 217.52M |
| 412 | JANX | Janux Therapeutics, Inc. | 630.80M | -3.73% | 980,519 | 23.29M |
| 413 | ABUS | Arbutus Biopharma Corporation | 630.03M | 1.48% | 2,902,404 | 181.49M |
| 414 | BCAX | Bicara Therapeutics Inc. | 622.71M | -2.29% | 1,302,236 | - |
| 415 | OLMA | Olema Oncology, Inc. | 618.50M | -2.22% | 1,177,994 | - |
| 416 | DSGN | Design Therapeutics, Inc. | 606.42M | -3.76% | 319,943 | - |
| 417 | SRZN | Surrozen, Inc. | 605.02M | 5.87% | 312,924 | 10.53M |
| 418 | DBVT | DBV Technologies S.A. | 602.91M | -3.10% | 136,177 | 3.74M |
| 419 | SGHT | Sight Sciences, Inc. | 598.59M | 2.67% | 335,560 | 88.40M |
| 420 | IMMX | Immix Biopharma, Inc. | 595.91M | -1.25% | 876,386 | - |
| 421 | TCMD | Tactile Systems Technology, Inc. | 591.84M | 1.42% | 218,784 | 356.42M |
| 422 | FDMT | 4D Molecular Therapeutics, Inc. | 589.73M | -3.06% | 679,698 | 96.06M |
| 423 | OBIO | Orchestra BioMed Holdings, Inc. | 587.14M | 7.03% | 1,204,385 | 31.21M |
| 424 | CGEM | Cullinan Therapeutics, Inc. | 584.94M | -2.91% | 1,064,067 | - |
| 425 | PACB | Pacific Biosciences of California, Inc. | 572.66M | 0.55% | 15,315,681 | 161.39M |
| 426 | ALMS | Alumis Inc. | 570.56M | -9.19% | 2,016,377 | 7.24M |
| 427 | ENTX | Entera Bio Ltd. | 567.69M | 8.67% | 493,397 | 42.00K |
| 428 | AVBP | ArriVent BioPharma, Inc. | 563.78M | 1.96% | 2,696,657 | 5.00M |
| 429 | ANL | Adlai Nortye Group Ltd. | 562.84M | -7.81% | 455,143 | 18.06M |
| 430 | NRC | NRC Health | 555.16M | 1.04% | 94,366 | 143.79M |
| 431 | ACRS | Aclaris Therapeutics, Inc. | 555.14M | 3.55% | 2,940,514 | 6.40M |
| 432 | SANA | Sana Biotechnology, Inc. | 554.32M | -1.60% | 2,659,563 | - |
| 433 | ZVRA | Zevra Therapeutics, Inc. | 552.20M | -1.28% | 623,082 | 147.76M |
| 434 | DNA | Ginkgo Bioworks Holdings, Inc. | 547.06M | 1.44% | 2,361,299 | 130.75M |
| 435 | WVE | Wave Life Sciences, Inc. | 546.32M | -2.46% | 2,208,031 | 70.92M |
| 436 | CLYM | Climb Bio, Inc. | 546.27M | -4.91% | 865,345 | - |
| 437 | SENS | Senseonics Holdings, Inc. | 533.56M | -4.13% | 867,085 | 60.01M |
| 438 | RCEL | AVITA Medical, Inc. | 533.30M | 6.72% | 715,992 | 84.68M |
| 439 | EVO | Evotec SE | 531.69M | -1.35% | 35,786 | 815.72M |
| 440 | CBIO | Crescent Biopharma, Inc. | 530.73M | -4.91% | 327,365 | 15.00M |
| 441 | MYGN | Myriad Genetics, Inc. | 530.45M | -0.18% | 1,257,044 | 803.60M |
| 442 | ETRA | Electra Therapeutics, Inc. | 529.13M | 0.96% | 323,440 | - |
| 443 | AVR | Anteris Technologies Global Corp. | 507.94M | -2.07% | 1,255,199 | 2.33M |
| 444 | VALN | Valneva SE | 507.35M | -4.13% | 4,817 | 163.30M |
| 445 | INDP | Indaptus Therapeutics, Inc. | 505.28M | -0.90% | 166,763 | - |
| 446 | HELP | Helus Pharma Inc. | 503.38M | -4.31% | 3,245,957 | - |
| 447 | TKNO | Alpha Teknova, Inc. | 495.68M | 3.01% | 304,561 | 45.95M |
| 448 | RGNX | REGENXBIO Inc. | 480.05M | 0.28% | 701,889 | 153.91M |
| 449 | MNPR | Monopar Therapeutics Inc. | 479.46M | -0.44% | 102,622 | - |
| 450 | NGNE | Neurogene Inc. | 479.02M | 0.17% | 248,968 | 925.00K |
| 451 | ANGO | AngioDynamics, Inc. | 476.06M | -1.48% | 322,965 | 325.38M |
| 452 | KMDA | Kamada Ltd. | 476.03M | -1.10% | 159,240 | 196.87M |
| 453 | CARL | Carlsmed, Inc. | 476.01M | -2.09% | 188,237 | 71.78M |
| 454 | AQST | Aquestive Therapeutics, Inc. | 475.10M | 2.16% | 1,806,315 | 48.84M |
| 455 | GYRE | Gyre Therapeutics, Inc. | 475.02M | -4.82% | 466,554 | 110.06M |
| 456 | FENC | Fennec Pharmaceuticals Inc. | 470.62M | -1.84% | 591,909 | 66.37M |
| 457 | EOLS | Evolus, Inc. | 467.95M | 5.68% | 802,520 | 325.47M |
| 458 | CAPR | Capricor Therapeutics, Inc. | 466.88M | -4.52% | 8,383,545 | 11.13M |
| 459 | MDXG | MiMedx Group, Inc. | 464.04M | 0.00% | 1,513,268 | 303.73M |
| 460 | BLSM | BlossomHill Therapeutics, Inc. | 463.74M | -3.57% | 280,081 | - |
| 461 | DMAC | DiaMedica Therapeutics Inc. | 463.49M | 2.51% | 207,418 | - |
| 462 | ASMB | Assembly Biosciences, Inc. | 458.49M | -0.49% | 486,994 | 67.01M |
| 463 | OCS | Oculis Holding AG | 456.20M | -1.60% | 311,564 | 1.12M |
| 464 | STTK | Shattuck Labs, Inc. | 455.24M | -2.61% | 2,075,290 | 1.00M |
| 465 | RZLT | Rezolute, Inc. | 445.84M | 5.85% | 2,931,650 | - |
| 466 | EVH | Evolent Health, Inc. | 444.50M | -14.94% | 3,097,228 | 2.34B |
| 467 | SRTA | Strata Critical Medical, Inc. | 443.03M | -5.34% | 993,385 | 280.76M |
| 468 | ARVN | Arvinas, Inc. | 443.01M | -0.81% | 1,085,278 | 275.30M |
| 469 | IRLA | IRulya Therapeutics Inc. | 440.06M | 5.57% | 119,776 | - |
| 470 | MOBI | Mobia Medical, Inc. | 434.26M | 3.33% | 212,747 | 51.89M |
| 471 | SI | Shoulder Innovations, Inc. | 432.05M | 0.44% | 90,317 | 64.49M |
| 472 | PRTA | Prothena Corporation plc | 428.77M | 1.09% | 764,256 | 52.74M |
| 473 | OVID | Ovid Therapeutics Inc. | 426.53M | 1.80% | 2,153,759 | 1.45M |
| 474 | TVGN | Tevogen Inc. | 421.69M | 7.91% | 4,982 | - |
| 475 | PHAT | Phathom Pharmaceuticals, Inc. | 420.98M | -3.64% | 1,674,821 | 274.88M |
| 476 | CADL | Candel Therapeutics, Inc. | 417.33M | -1.48% | 1,389,687 | - |
| 477 | EPRX | Eupraxia Pharmaceuticals Inc. | 415.85M | -6.19% | 1,212,153 | - |
| 478 | TECX | Tectonic Therapeutic, Inc. | 411.32M | 4.78% | 169,433 | - |
| 479 | CTMX | CytomX Therapeutics, Inc. | 409.85M | -3.09% | 4,386,509 | 14.03M |
| 480 | MASS | 908 Devices Inc. | 395.86M | 1.38% | 253,703 | 65.79M |
| 481 | CERS | Cerus Corporation | 391.79M | 2.11% | 6,088,374 | 226.57M |
| 482 | AVTX | Avalo Therapeutics, Inc. | 387.41M | -6.03% | 1,580,805 | 59.00K |
| 483 | ALEC | Alector, Inc. | 382.61M | 0.39% | 2,133,488 | 173.47M |
| 484 | CTEV | Claritev Corporation | 380.77M | -2.83% | 313,116 | 1.02B |
| 485 | IRD | Opus Genetics, Inc. | 378.88M | -3.21% | 751,576 | 7.91M |
| 486 | SLBT | SL Science Holding Limited | 376.32M | 3.90% | 20,111 | 3.27M |
| 487 | MPLT | MapLight Therapeutics, Inc. | 373.78M | 1.22% | 416,883 | - |
| 488 | PBYI | Puma Biotechnology, Inc. | 373.26M | 1.12% | 454,054 | 231.83M |
| 489 | SPRY | ARS Pharmaceuticals, Inc. | 370.95M | 1.10% | 1,695,612 | 122.14M |
| 490 | BWAY | BrainsWay Ltd. | 370.77M | -1.43% | 148,396 | 60.70M |
| 491 | CV | CapsoVision, Inc. | 365.62M | 2.56% | 159,741 | 13.92M |
| 492 | CTNM | Contineum Therapeutics, Inc. | 362.82M | -3.25% | 204,006 | - |
| 493 | CRMD | CorMedix Inc. | 357.92M | -3.64% | 1,601,377 | 412.49M |
| 494 | ASPE | Aspen Neuroscience, Inc. | 349.23M | 0.08% | 289,107 | - |
| 495 | EMBC | Embecta Corp. | 345.06M | -0.98% | 716,062 | 1.02B |
| 496 | YDES | YD Bio Limited | 343.53M | 2.54% | 21,734 | 1.24M |
| 497 | LYEL | Lyell Immunopharma, Inc. | 341.49M | 1.61% | 116,090 | 15.00K |
| 498 | PRLD | Prelude Therapeutics Incorporated | 340.76M | -0.60% | 230,538 | 21.57M |
| 499 | LRMR | Larimar Therapeutics, Inc. | 339.06M | 7.86% | 1,407,246 | - |
| 500 | VMD | Viemed Healthcare, Inc. | 332.70M | -3.20% | 257,462 | 310.37M |